Prostacyclin versus citrate in continuous haemodiafiltration: An observational study in patients with high risk of bleeding

Blood Purification

Volumn 23, Issue 4, 2005, Pages 325-329

  Balik, M ^a,b   Waldauf, P ^a   Plasil P ^a   Pachl, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Acute renal failure; Citrate; Haemodiafiltration; Prostacyclin; Renal replacement therapy

Indexed keywords

CITRIC ACID; HEPARIN; PROSTACYCLIN;

ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HUMAN; HYPOTENSION; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA;

AGED; ANTICOAGULANTS; BLOOD PLATELETS; CITRIC ACID; EPOPROSTENOL; FEMALE; GLUCOSE; HEMODIAFILTRATION; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 24944534015     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087770     Document Type: Article

References (21)

1. Cole L, Bellomo R, Davenport P, Tipping P, Ronco C: Cytokine removal during continuous renal replacement therapy: an ex vivo comparison of convection and diffusion. Int J Artif Organs 2004;27:388-397.
2. Ronco C, Tetta C, Lupi A, Galloni E, Bettini MC, Sereni L, Mariano F, DeMartino A, Montrucchio G, Camussi G: Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 1995;23:99-107.
3. Tan HK, Baldwin I, Bellomo R: Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000;26:1652-1657.
4. Uchino S, Fealy N. Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit 'down-time' on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575-578.
5. Cutts MW, Thomas AN, Kishen R: Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med 2000;26:1694-1697.
6. Fiaccadori E, Maggiore U, Rotelli C, Minari M, Melfa L, Cappe G, Cabassi A: Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Med 2002;28:586-593.
7. Langenecker SA, Felfernig M, Werba A, et al: Anticoagulation with prostacyclin and heparin during continuous venovenous hemodiafiltration. Crit Care Med 1994;22:1774-1781.
8. Van de Watering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between circuit coagulation and patient hemorrhage. J Am Soc Nephrol 1996;7:145-150.
9. Morgera S, Woydt R, Kern H, Schmutzler M, DeJonge K, Lun A, Rohde W, Konertz W, Kox W, Neumayer H: Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med 2002;30:107-112.
10. 2): new aspects of an old substance in the treatment of critically ill patients. Intensive Care Med 1997;23:146-158.
11. Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Kuebler WM, Bruhn S, Koehler C, Zwissler B: The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo. Intensive Care Med 2003;29:1574-1583.
12. Kieler-Jensen N, Houltz E, Ricksten SE: A comparison of prostacycline and sodium nitroprusside for the treatment of heart failure after cardiac surgery. J Cardiothorac Vasc Anesth 1995;9:641-646.
13. Mehta RL, Dobos GJ, Ward DM: Anticoagulation in continuous renal replacement procedures. Semin Dial 1992;5:61-68.
14. Tolwani AJ, Campbell RC. Schenk MB, Allon M, Warnock DG: Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-374.
15. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-1997.
16. Evenepoel P, Maes B, Vanwalleghem J, Kuypers D, Messiaen T, Vanrenterghem Y: Regional citrate anticoagulation for hemodialysis using conventional calcium containing dialysate. Am J Kidney Dis 2002;39:315-323.
17. Dorval M, Madore F, Courteau S, Leblanc M: A novel citrate anticoagulation regimen for continuous venovenous haemodiafiltration. Intensive Care Med 2003;29:1186-1189.
18. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A: Citrate pharmacokinetics and metabolism in cirrhotic and non-cirrhotic critically ill patients. Crit Care Med 2003;31:2450-2455.
19. Kriesche HU, Gitomer J, Finkel K, DuBose T: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-752.
20. Bollmann MD, Revelly JP, Tappy L, Berger MM, Schaller MD, Cayeux MC, Martinez A, Chiolero RL: Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during haemodiafiltration in patients with multiple organ failure. Intensive Care Med 2004;30:1103-1110.
21. Davenport A, Will EJ, Davison AM: Comparison of the use of standard heparin and prostacycline anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994;66:431-437.